Overview
Efficacy of Pilocarpine 1% in Presbyopia
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2023-03-30
2023-03-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
In this before-after interventional study on patients with presbyopia after cataract surgery, uncorrected distance vision and corrected distance visual acuity are measured and recorded by Snellen chart. Corrected near visual acuity from a distance of 40 cm is measured by the standard near vision chart (Rosenbaum near vision card). Twenty minutes after the administration of pilocarpine 1%, the corrected near and far visual acuity is measured again. Also, the relationship between the difference in average near visual acuity after the administration of 1% pilocarpine in pseudophakic people is measured with iris color and pupil size.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Isfahan University of Medical SciencesTreatments:
Pilocarpine
Criteria
Inclusion Criteria:- Informed consent to participate in the study
- Previous uncomplicated cartaract surgery and PCIOL insertion
- BCDVA eqaul to or more than 8/10
- Less than 1.5 diopter cylindrical refractive error
- Spherical refractive error between -0.5_+1.5
- No history of previous eye disease
- Not using drugs that interact with pilocarpine
Exclusion Criteria:
- Occurrence of any drug-related complications
- Unable to follow up the patient after prescribing the drug